BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24330082)

  • 21. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W; Su J; Xu S; Yan D
    J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of IGS1, ITS and D1/D2 regions in molecular identification of Trichosporon species and genotype of T. asahii in China].
    Xia ZK; Yang RY; Wang WL; Ao JH; Wang CM; Zhu H
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3145-8. PubMed ID: 19159600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Trichosporon spp. strains by sequencing D1/D2 region and sub-typing by sequencing ribosomal intergenic spacer region of ribosomal DNA.
    Zeng J; de Souza Motta CM; Fukushima K; Takizawa K; Magalhes OM; Neves RP; Nishimura K
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):655-8. PubMed ID: 19821104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
    Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-healing ulcer due to Trichosporon loubieri in an immunocompetent host and review of published reports.
    Rastogi V; Rudramurthy SM; Maheshwari M; Nirwan PS; Chakrabarti A; Batra S
    Mycopathologia; 2013 Aug; 176(1-2):107-11. PubMed ID: 23591623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiological characteristics of medically important Trichosporon species.
    Li HM; Du HT; Liu W; Wan Z; Li RY
    Mycopathologia; 2005 Oct; 160(3):217-25. PubMed ID: 16205970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY; Chien JY; Hsueh PR
    Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
    Escribano P; Peláez T; Recio S; Bouza E; Guinea J
    Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.
    Metin DY; Hilmioglu-Polat S; Hakim F; Inci R; Tumbay E
    J Chemother; 2005 Aug; 17(4):404-8. PubMed ID: 16167520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichosporon insectorum sp. nov., a new anamorphic basidiomycetous killer yeast.
    Fuentefria AM; Suh SO; Landell MF; Faganello J; Schrank A; Vainstein MH; Blackwell M; Valente P
    Mycol Res; 2008 Jan; 112(Pt 1):93-9. PubMed ID: 18222677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
    Almeida AA; Crispim Bdo A; Grisolia AB; Svidzinski TI; Ortolani LG; Oliveira KM
    Rev Argent Microbiol; 2016; 48(1):62-6. PubMed ID: 26916812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of
    Francisco EC; de Almeida Junior JN; Queiroz-Telles F; Aquino VR; Mendes AVA; de Oliveira Silva M; Castro PTOE; Guimarães T; Ponzio V; Hahn RC; Chaves GM; Colombo AL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318016
    [No Abstract]   [Full Text] [Related]  

  • 39. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
    Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
    Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
    Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
    J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.